Cambivac

Cambivac develops and licenses veterinary vaccine technologies, combining genomic research with traditional virology and molecular approaches.

Its documented development programmes include vaccines for foot-and-mouth disease and porcine reproductive and respiratory syndrome, a respiratory disease affecting pigs. The company has also investigated approaches to vaccine attenuation and synthetic antigen production.

Based in the Cambridge area, Cambivac works to translate vaccine research into technologies for pharmaceutical manufacturing partners.